Home Infusion Therapy Market Size – Trends Report, 2034

Home Infusion Therapy Market - By Product, By Application, By Distribution Channel - Global Forecast, 2025-2034

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology and Scope

1.1&nbsp;&nbsp;&nbsp; Market scope and definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Data mining sources

1.3.1&nbsp;&nbsp;&nbsp; Global

1.3.2&nbsp;&nbsp;&nbsp; Regional/country

1.4&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.4.1&nbsp;&nbsp;&nbsp; Base year calculation

1.4.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.6&nbsp;&nbsp;&nbsp; Forecast model

1.7&nbsp;&nbsp;&nbsp; Research assumptions and limitations

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

2.2&nbsp;&nbsp;&nbsp; Key market trends

2.2.1&nbsp;&nbsp;&nbsp; Regional trends

2.2.2&nbsp;&nbsp;&nbsp; Product trends

2.2.3&nbsp;&nbsp;&nbsp; Application trends

2.2.4&nbsp;&nbsp;&nbsp; Distribution channel trends

2.3&nbsp;&nbsp;&nbsp; CXO perspectives: Strategic imperatives

2.3.1&nbsp;&nbsp;&nbsp; Key decision points for industry executives

2.3.2&nbsp;&nbsp;&nbsp; Critical success factors for market players

2.4&nbsp;&nbsp;&nbsp; Future outlook and strategic recommendations

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing hospital acquired infections

3.2.1.2&nbsp;&nbsp;&nbsp; Rising prevalence of chronic diseases

3.2.1.3&nbsp;&nbsp;&nbsp; Advancements in technology

3.2.1.4&nbsp;&nbsp;&nbsp; Growing geriatric population

3.2.1.5&nbsp;&nbsp;&nbsp; Increasing preference towards at-home healthcare solutions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Dearth of reimbursement

3.2.2.2&nbsp;&nbsp;&nbsp; Safety concerns and risk of failure associated with home infusion devices

3.2.3&nbsp;&nbsp;&nbsp; Market opportunities

3.2.3.1&nbsp;&nbsp;&nbsp; Increasing adoption of intravenous immunoglobulin (IVIG) therapy

3.2.3.2&nbsp;&nbsp;&nbsp; Growing demand for personalized care

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.4.1&nbsp;&nbsp;&nbsp; North America

3.4.2&nbsp;&nbsp;&nbsp; Europe

3.4.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.5.1&nbsp;&nbsp;&nbsp; Current technological trends

3.5.2&nbsp;&nbsp;&nbsp; Emerging technologies

3.6&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.7&nbsp;&nbsp;&nbsp; Trends in home infusion therapy industry

3.8&nbsp;&nbsp;&nbsp; Pricing analysis, 2024

3.9&nbsp;&nbsp;&nbsp; Future prospects for home infusion therapy industry

3.10&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.11&nbsp;&nbsp;&nbsp; PESTEL analysis

3.12&nbsp;&nbsp;&nbsp; Gap analysis

3.13&nbsp;&nbsp;&nbsp; Start-up scenario

3.14&nbsp;&nbsp;&nbsp; Consumer behaviour analysis

3.15&nbsp;&nbsp;&nbsp; Value chain analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2024

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.3.1&nbsp;&nbsp;&nbsp; Global

4.3.2&nbsp;&nbsp;&nbsp; North America

4.3.3&nbsp;&nbsp;&nbsp; Europe

4.3.4&nbsp;&nbsp;&nbsp; Asia Pacific

4.3.5&nbsp;&nbsp;&nbsp; LAMEA

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Key developments

4.6.1&nbsp;&nbsp;&nbsp; Mergers &amp; acquisitions

4.6.2&nbsp;&nbsp;&nbsp; Partnerships &amp; collaborations

4.6.3&nbsp;&nbsp;&nbsp; New product launches

4.6.4&nbsp;&nbsp;&nbsp; Expansion plans

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Infusion pumps

5.2.1&nbsp;&nbsp;&nbsp; Syringe

5.2.2&nbsp;&nbsp;&nbsp; Volumetric

5.2.3&nbsp;&nbsp;&nbsp; Ambulatory

5.2.4&nbsp;&nbsp;&nbsp; Insulin

5.2.5&nbsp;&nbsp;&nbsp; Other infusion pumps

5.3&nbsp;&nbsp;&nbsp; Needleless connectors

5.4&nbsp;&nbsp;&nbsp; Intravenous sets

5.5&nbsp;&nbsp;&nbsp; IV cannulas

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Anti-infective

6.3&nbsp;&nbsp;&nbsp; Enteral nutrition

6.4&nbsp;&nbsp;&nbsp; Specialty pharmaceuticals

6.5&nbsp;&nbsp;&nbsp; Parenteral nutrition

6.6&nbsp;&nbsp;&nbsp; Hydration therapy

6.7&nbsp;&nbsp;&nbsp; Chemotherapy

6.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Direct sales

7.3&nbsp;&nbsp;&nbsp; Indirect sales

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; AMSINO

9.2&nbsp;&nbsp;&nbsp; B. BRAUN

9.3&nbsp;&nbsp;&nbsp; Baxter

9.4&nbsp;&nbsp;&nbsp; Becton Dickinson and Company

9.5&nbsp;&nbsp;&nbsp; Contec Medical Systems

9.6&nbsp;&nbsp;&nbsp; ERENLER MEDIKAL

9.7&nbsp;&nbsp;&nbsp; FRESENIUS KABI

9.8&nbsp;&nbsp;&nbsp; Halyard Health (AVANOS)

9.9&nbsp;&nbsp;&nbsp; ICU Medical

9.10&nbsp;&nbsp;&nbsp; JMS

9.11&nbsp;&nbsp;&nbsp; Mindray

9.12&nbsp;&nbsp;&nbsp; Moog

9.13&nbsp;&nbsp;&nbsp; NIPRO

9.14&nbsp;&nbsp;&nbsp; POLYMED

9.15&nbsp;&nbsp;&nbsp; TERUMO 
&nbsp;

Home Infusion Therapy Market

Get a free sample of this report